198 filings
Page 4 of 10
8-K
u80x0wz0y5 1ony
13 Sep 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:24pm
8-K
vt70ui
5 Sep 19
Alimera Sciences Board of Directors Approves Reverse Stock Split and 10b5-1 Stock Purchase Plan for U.S. Executive Management
8:20am
8-K
sstx6ss8
30 Jul 19
Alimera Sciences Announces Second Quarter 2019 Financial Results and Provides Corporate Update
8:10am
8-K
7086vhidzgu1s
19 Jul 19
Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
9:03am
8-K
gtit kz81c
19 Jun 19
Departure of Directors or Certain Officers
5:21pm
8-K
zyfom
4 Jun 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
4mnmam4utxm9b
8 May 19
Departure of Directors or Certain Officers
4:32pm
8-K
54ph cu4069cf1h
1 May 19
Departure of Directors or Certain Officers
4:22pm
8-K
8h19 2ijuhf2gndqqrm
30 Apr 19
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview
8:08am
8-K
cemgiq7srusi
9 Apr 19
Alimera Sciences Announces Expansion of Leadership Team with Appointment of Samer Kaba, MD as Chief Medical Officer
5:20pm
8-K
gajmjxchlz1qyxxve
29 Mar 19
Termination of a Material Definitive Agreement
4:45pm
8-K
eery9xkkmi
1 Mar 19
Departure of Directors or Certain Officers
4:41pm
8-K
vkwqi
25 Feb 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:07pm
8-K
s2slcn
19 Feb 19
Alimera Sciences Reports Record Fourth Quarter and 2018 Results
6:35am
8-K/A
j9gfs
25 Jan 19
Departure of Directors or Certain Officers
4:21pm
8-K
7ka1hqwe4h31 pc2rx
18 Jan 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm
8-K
kusn yeg6mqb5ql
7 Jan 19
Alimera Sciences Affirms Record 2018 Revenues
8:26am
8-K
yru2net
2 Jan 19
Departure of Directors or Certain Officers
4:20pm
8-K
k6kp4cgyeeldrd
6 Dec 18
Regulation FD Disclosure
9:29am
8-K
8wj1qzf93n2dy
29 Nov 18
Alimera Sciences Appoints Rick Eiswirth as Chief Executive Officer
8:33am